Clinical outcomes of retreatment with daratumumab-based regimens in anti-CD38 refractory multiple myeloma

被引：0
|
作者：
Tan, Carlyn Rose Co
Rueda, Colin
Shekarkhand, Tala
Derkach, Andriy
Korde, Neha
Maclachlan, Kylee
Hultcrantz, Malin
Hassoun, Hani
Mailankody, Sham
Shah, Urvi A.
Rajeeve, Sridevi
Lahoud, Oscar Boutros
Shah, Gunjan L.
Scordo, Michael
Chung, David J.
Landau, Heather Jolie
Giralt, Sergio
Usmani, Saad Zafar
Lesokhin, Alexander M.
机构：
[1] Mem Sloan Kettering Canc Ctr, Dept Med, Myeloma Serv, New York, NY USA
[2] Mem Sloan Kettering Canc Ctr, Dept Epidemiol & Biostat, New York, NY USA
[3] Mem Sloan Kettering Canc Ctr, New York, NY USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
7570
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Efficacy of Daratumumab-Based Regimens in Anti-CD38 Treatment-Naive Relapsed/Refractory Multiple Myeloma with High-Risk Cytogenetics
    Snyder, Jordan
    Mansour, Razan
    Mammadzadeh, Aytaj
    Hashmi, Hamza
    Afrough, Aimaz
    Alkharabsheh, Omar
    Paul, Barry
    Atrash, Shebli
    Mushtaq, Muhammad Umair
    Skikne, Barry S.
    Ahmed, Nausheen
    Abdallah, Al-Ola
    BLOOD, 2023, 142
  • [2] CLINICAL OUTCOMES ASSOCIATED WITH ANTI-CD38 RETREATMENT IN RELAPSED/REFRACTORY MULTIPLE MYELOMA: A REVIEW OF THE LITERATURE
    McNamara, S.
    Chorazy, J.
    Pandey, A.
    Bitetti, J.
    Boytsov, N.
    Purser, M.
    Iheanacho, I.
    VALUE IN HEALTH, 2024, 27 (06) : S31 - S31
  • [3] Mechanisms of Resistance to Anti-CD38 Daratumumab in Multiple Myeloma
    Saltarella, Ilaria
    Desantis, Vanessa
    Melaccio, Assunta
    Solimando, Antonio Giovanni
    Lamanuzzi, Aurelia
    Ria, Roberto
    Storlazzi, Clelia Tiziana
    Mariggio, Maria Addolorata
    Vacca, Angelo
    Frassanito, Maria Antonia
    CELLS, 2020, 9 (01)
  • [4] Clinical efficacy of retreatment of daratumumab-based therapy (D2) in daratumumab-refractory multiple myeloma
    Abdallah, Al-Ola
    Mahmoudjafari, Zahra
    Ahmed, Nausheen
    Cui, Wei
    Shune, Leyla
    McGuirk, Joseph
    Mohan, Meera
    Mohyuddin, Ghulam Rehman
    Afrough, Aimaz
    Alkharabsheh, Omar
    Atrash, Shebli
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2023, 110 (06) : 626 - 632
  • [5] Management and Outcomes of Anti-CD38 Refractory Myeloma Patients: The Impact of Retreatment and of Subsequent Therapies
    Kastritis, Efstathios
    Theodorakakou, Foteini
    Ntanasis-Stathopoulos, Ioannis
    Spiliopoulou, Vasiliki
    Solia, Eirini
    Malandrakis, Panagiotis
    Syrigou, Rodanthi
    Kokkali, Nikoletta-Aikaterini
    Migkou, Magdalini
    Papaiakovou, Evangelos Eleutherakis
    Fotiou, Despina
    Roussou, Maria
    Kanellias, Nikolaos
    Gavriatopoulou, Maria
    Terpos, Evangelos
    Dimopoulos, Meletios A.
    BLOOD, 2022, 140 : 7324 - 7325
  • [6] DARATUMUMAB Anti-CD38 Monoclonal Antibody, Treatment of Multiple Myeloma
    Richardson, P.
    Lokhorst, H.
    Palumbo, A.
    Nahi, H.
    Laubach, J.
    Gimsing, P.
    Lisby, S.
    Cakana, A.
    Brun, N. Constantin
    Plesner, T.
    DRUGS OF THE FUTURE, 2013, 38 (08) : 545 - 554
  • [7] Myeloma Drug Sensitivity Testing to Optimize Retreatment with Anti-CD38 Monoclonal Antibodies in Daratumumab-Refractory Patients
    De Acha, Olivia Perez
    Idler, Beau M.
    Walker, Zachary J.
    Forsberg, Peter A.
    Mark, Tomer M.
    Sherbenou, Daniel W.
    BLOOD, 2020, 136
  • [8] Treatment of Multiple Myeloma in Patients Refractory to Daratumumab/Anti-CD38 Monoclonal Antibodies: A Systematic Review
    Tan, Chia Jie
    Kacerek, Dylan
    Kampirapawong, Nattawara
    Godara, Amandeep
    Chaiyakunapruk, Nathorn
    CANCER MEDICINE, 2025, 14 (05):
  • [9] Serological Investigation in a Multiple Myeloma Patient receiving Daratumumab (Anti-CD38)
    Oldfield, L.
    Ison, T.
    Lau, W.
    TRANSFUSION, 2016, 56 : 135A - 136A
  • [10] Daratumumab-Based Regimens with Prior Carfilzomib in Patients with Relapsed Refractory Multiple Myeloma (RRMM)
    Tungesvik, Alexandre
    Huang, Jessica
    Sudalagunta, Praneeth
    Dimaggio, Elizabeth
    De Avila, Gabe
    Tandon, Ankita
    Nelson, Rebeccah
    Olson, Laura
    Tobon, Katherine
    Shain, Kenneth
    Brayer, Jason
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2019, 19 : S327 - S328
12345